
Why balancing risk factors to foster breakthrough science remains one of the key challenges in R&D leaderships.
Alistair leads UCB's global research and early development organisation with a mission to bring scientific innovation to patients living with severe diseases. A biophysicist by training and drug discovery leader by experience, Alistair has played a pivotal role in advancing UCB's biologics platform and integrating AI and data science into modern pharmaceutical R&D.